Great Point Partners’s Alimera Sciences ALIM Stock Holding History

Great Point Partners’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-4,953	Closed	-$279K	–	35
2013 Q3	$279K	Buy	+4,953	New	+$311K	0.19%	29

Other funds holding ALIM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Great Point Partners's ALIM Position: Q1 2017 in Review

Great Point Partners sold out of Alimera Sciences (ALIM) in Q1 2017, closing a stake of 152,912 shares — an estimated $2.48M sold.

Great Point Partners first reported a position in ALIM in Q1 2014 and held it in 9 quarters. The position peaked at $14.5M in Q4 2014. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2017.

Great Point Partners reported no remaining Alimera Sciences position as of Q1 2017 after selling out during the quarter.
Great Point Partners sold 152,912 Alimera Sciences shares in Q1 2017, an estimated $2.48M.
Great Point Partners first reported a position in Alimera Sciences in Q1 2014 and held it in 9 quarters.
Great Point Partners's Alimera Sciences position peaked at $14.5M in Q4 2014.
39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2017.

Based on Great Point Partners's 13F filing for Q1 2017, filed 15 May 2017.